Tempraxine

Tempraxine is an experimental drug with mainly unknown purposes and side-effects. It seems to have been developed by Ansar Jilani for Sağlık Pharmaceuticals in 2017 as a means of regenerating organic tissue, but was later in use by Jonas Gessner, who used it on Sarah Cunnington during her visit to Geneva. ("Geneva", "Jilani")
According to Adil Kurtuluş, the drug is based on a chemical compound called dopamine, which is generally responsible for transmitting signals between the neurons in the brain, and was named for the effect it has on the temporal processing of the mind. ("Adam")Category:Terms